The Clinical Utility of Autoantibodies in Patients with Idiopathic Granulomatous Mastitis

The Clinical Utility of Autoantibodies in Patients with Idiopathic Granulomatous Mastitis

Background Although the etiopathogenesis of idiopathic granulomatous mastitis (IGM) is still controversial, recently autoimmunity and immune dysregulation have been emphasized. The aim of this study is to investigate the clinical utility of autoantibodies in IGM. Material and Methods Rheumatoid fact...

Full description

Bibliographic Details
Main Author:	Hande Koksal
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2022-02-01
Series:	Journal of Investigative Surgery
Subjects:	rheumatoid factor antinuclear antibody anti-double stranded dna antibody anti-cyclic citrullinated peptides antibody perinuclear anti-neutrophil cytoplasmic antibody idiopathic granulomatous mastitis
Online Access:	http://dx.doi.org/10.1080/08941939.2020.1861666

Similar Items

Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis
by: Shawn A. Mahmud, et al.
Published: (2019-01-01)

The Impact of Autoantibodies on Outcomes in Patients with Idiopathic Pulmonary Fibrosis: Post-Hoc Analyses of the Phase III ASCEND Trial
by: Tejaswini Kulkarni, et al.
Published: (2024-07-01)

Autoantibodies in Wilson disease: Impact on clinical course
by: Magdalena Antczak‐Kowalska, et al.
Published: (2022-09-01)

Classic polyarteritis nodosa presenting initially as a case of cutaneous polyarteritis nodosa: A case report
by: Sabina Adhikari
Published: (2024-06-01)

ANTI NEUTROPHIL CYTOPLASMIC AUTOANTIBODIES IN UVEITIS
by: M. Vndjgani, et al.
Published: (2000-04-01)

An Unusual Presentation of Granulomatosis with Polyangiitis
by: Rakhee Sodhi, et al.
Published: (2017-09-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Clinical, Immunological and Inflammatory Characteristics among Mexican Children with Different Subtypes of Juvenile Idiopathic Arthritis: Exploring the Correlation between Anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF)
by: Hayde Guadalupe Hernández-Huirache, et al.
Published: (2024-02-01)

Autoantibodies and SARS-CoV-2 infection: A case report
by: T. I. Kalenchic, et al.
Published: (2022-07-01)

The clinical aspect of overweight on rheumatoid arthritis and disease activity
by: Haitham Ahmed, et al.
Published: (2019-06-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies, adenosine deaminase activity and other potential biomarkers for predicting and monitoring rheumatoid arthritis
by: Mehanović-Nikolić Jasminka, et al.
Published: (2008-01-01)

Detection and clinical significance of anti-carbamylated protein antibody in serologically negative patients with rheumatoid arthritis
by: Wu Tao, Chen Chutao, Yang Lijuan, Zou Yaowei, Ma Jianda, Xu Yanhui, Jia Lei, Dai Lie
Published: (2022-04-01)

The diagnostic value of anti-cyclic citrullinated peptide antibodies (anti-CCP) in patients with rheumatoid arthritis
by: Damjanovska Ljubinka, et al.
Published: (2007-01-01)

Epitope Specificity of Anti-Citrullinated Protein Antibodies
by: Nicole H. Trier, et al.
Published: (2017-03-01)

Abatacept reduces disease activity of rheumatoid arthritis independently of modulating anti-citrullinated peptide antibody production
by: Hisakata Yamada, et al.
Published: (2020-04-01)

Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
by: Sung Soo Ahn, et al.
Published: (2022-04-01)

Presence of autoantibodies in “seronegative” rheumatoid arthritis associates with classical risk factors and high disease activity
by: Evan Reed, et al.
Published: (2020-07-01)

Serum sirtuin-1 a potential marker in the diagnosis of rheumatoid arthritis
by: Liming Tan, et al.
Published: (2023-12-01)

Performance of two multiplex flow cytometric assays for antibody detection in Egyptian patients
by: Alshymaa A. Ahmed, et al.
Published: (2023-05-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

Bilateral Pleural Effusion as the Initial Manifestation of Rheumatoid Arthritis Without Articular İnvolvement: Case Report and Literature Review
by: Nurdan Yılmaz, et al.
Published: (2022-08-01)

Knee alterations in rheumatoid arthritis: Comparison of US and MRI
by: Xiao Lu, et al.
Published: (2021-06-01)

Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement
by: S.L.E. Ribeiro, et al.
Published: (2008-11-01)

Diagnostic Usefulness of Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin Antibodies in the Diagnosis of Seronegative Rheumatoid Arthritis Patients
by: Bushra Gohar Shah , Asma Saeed , Mohammad Faisal Khan , Hamid Javaid Quershi
Published: (2016-03-01)

Presence of autoantibodies and epidemiological characteristics of systemic sclerosis patients in western Paraná
by: Alana Rubia Balbinot, et al.
Published: (2022-10-01)

Relation of cytokine profile and antibody values to post-translational protein modifications in patients with rheumatoid arthritis (preliminary data)
by: D. А. Dibrov, et al.
Published: (2024-04-01)

Specificity of Anti-Citrullinated Protein Antibodies to Citrullinated α-Enolase Peptides as a Function of Epitope Structure and Composition
by: Ilaria Fanelli, et al.
Published: (2021-07-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
by: E. L. Nasonov
Published: (2017-04-01)

The Contribution of Serum Anti–cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 in Predicting the Activity of Rheumatoid Arthritis Disease
by: Aida R. Al-Derzi
Published: (2017-07-01)

Anti-Cyclic Citrullinated Peptide Antibody Index in the Cerebrospinal Fluid for the Diagnosis and Monitoring of Rheumatoid Meningitis
by: Luigi Caputi, et al.
Published: (2022-09-01)

The Clinical Impact of Seropositivity on Treatment Response in Patients with Rheumatoid Arthritis Treated with Etanercept: A Real-World Iraqi Experience
by: Ridha A, et al.
Published: (2022-06-01)

Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis
by: Senga F. Whittingham, et al.
Published: (2017-04-01)

Impact of Likelihood Ratios of Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibody in Clinical Diagnosis of Rheumatoid Arthritis by Two Available Platforms
by: Juan Irure-Ventura, et al.
Published: (2025-01-01)

When Autoantibodies Are Missing: The Challenge of Seronegative Rheumatoid Arthritis
by: Marino Paroli, et al.
Published: (2023-10-01)

Autoantibody profile in a cohort of South Indian children with Kawasaki disease
by: Suchetha Rao, et al.
Published: (2014-01-01)

Not all autoantibodies are clinically relevant. Classic and novel autoantibodies in Sjögren’s syndrome: A critical review
by: Francisco Vílchez-Oya, et al.
Published: (2022-10-01)

Changes in the gene expression of activation-induced cytidine deaminase in peripheral blood mononuclear cells in COVID-19 patients
by: Nioosha Ahmadi, et al.
Published: (2024-11-01)

Evaluation of a new biomarker 14-3-3 Eta protein in diagnosis of rheumatoid arthritis
by: Lakshmi Deepika Yarlagadda, et al.
Published: (2020-01-01)

Multicenter, observational clinical study of abatacept in Japanese patients with rheumatoid arthritis
by: Noriyoshi Ogawa, et al.
Published: (2019-01-01)

DIAGNOSTIC VALUE OF ANTI-PEPTIDYLARGININE DEIMINASE TYPE 4 (PADI-4) AND ANTI- CITRULLINATED PEPTIDE ANTIBODIES (ACCP) IN IRAQI PATIENTS WITH RHEUMATOID ARTHRITIS
by: Hassan J Hasony, et al.
Published: (2014-06-01)